Dengue virus infection causes dengue fever (DF), dengue hemorrhagic fever (
DHF), and dengue shock syndrome (DSS), whose pathogeneses are not clearly u
nderstood. Current hypotheses of antibody-dependent enhancement, virus viru
lence, and IFN-gamma /TNF alpha -mediated immunopathogenesis are insufficie
nt to explain clinical manifestations of DHF/DSS such as thrombocytopenia a
nd hemoconcentration. Dengue virus infection induces transient immune aberr
ant activation of CD4/CD8 ratio inversion and cytokine overproduction, and
infection of endothelial cells and hepatocytes causes apoptosis and dysfunc
tion of these cells. The coagulation and fibrinolysis systems are also acti
vated after dengue virus infection. We propose a new hypothesis for the imm
unopathogenesis for dengue virus infection. The aberrant immune responses n
ot only impair the immune response to clear the virus, but also result in o
verproduction of cytokines that affect monocytes, endothelial cells, and he
patocytes. Platelets are destroyed by crossreactive anti-platelet autoantib
odies. Dengue-virus-induced vasculopathy and coagulopathy must be involved
in the pathogenesis of hemorrhage, and the unbalance between coagulation an
d fibrinolysis activation increases the likelihood of severe hemorrhage in
DHF/DSS. Hemostasis is maintained unless the dysregulation of coagulation a
nd fibrinolysis persists. The overproduced IL-6 might play a crucial role i
n the enhanced production of anti-platelet or anti-endothelial cell autoant
ibodies, elevated levels of tPA, as well as a deficiency in coagulation. Ca
pillary leakage is triggered by the dengue virus itself or by antibodies to
its antigens. This immunopathogenesis of DHF/DSS can account for specific
characteristics of clinical, pathologic, and epidemiological observations i
n dengue virus infection. Copyright (C) 2001 National Science Council, ROC
and S. Karger AG, Basel.